{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:41:42Z","timestamp":1761561702203,"version":"3.40.4"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Juhnke Endowment Research Grant"},{"name":"SDSU Research Foundation (SR)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.pnpbp.2012.11.011","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T06:35:03Z","timestamp":1354170903000},"page":"44-51","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Antidepressant-like effects of lobeline in mice: Behavioral, neurochemical, and neuroendocrine evidence"],"prefix":"10.1016","volume":"41","author":[{"given":"Monzurul Amin","family":"Roni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shafiqur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2012.11.011_bb0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/FBP.0b013e32832c713e","article-title":"Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex","volume":"20","author":"Andreasen","year":"2009","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0269881108091587","article-title":"Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests","volume":"23","author":"Andreasen","year":"2009","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0015","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.alcohol.2009.09.027","article-title":"Nicotinic receptor ligands reduce ethanol intake by high alcohol-drinking HAD-2 rats","volume":"43","author":"Bell","year":"2009","journal-title":"Alcohol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(93)90498-7","article-title":"Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test","volume":"238","author":"Brioni","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0025","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2004.08.010","article-title":"High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation","volume":"56","author":"Caldarone","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0030","first-page":"417","article-title":"The role of the hippocampus in the pathophysiology of major depression","volume":"29","author":"Campbell","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0035","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0022-3565(24)36807-7","article-title":"Pharmacology of lobeline, a nicotinic receptor ligand","volume":"282","author":"Damaj","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","article-title":"Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test","volume":"29","author":"Dulawa","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0045","doi-asserted-by":"crossref","first-page":"S348","DOI":"10.1016\/S0924-977X(07)70506-0","article-title":"Mecamylamine as an augmentation treatment for depressed patients who were non-responders to citalopram","volume":"17","author":"Dunbar","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0022-3565(24)37467-1","article-title":"Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone","volume":"285","author":"Duncan","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0006-2952(01)00899-1","article-title":"A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse","volume":"63","author":"Dwoskin","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-009-1694-1","article-title":"The serotonin 5-HT 2A receptor agonist TCB-2: a behavioral and neurophysiological analysis","volume":"212","author":"Fox","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(02)00029-0","article-title":"Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors","volume":"320","author":"Fujino","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1471-4159.1998.70020663.x","article-title":"Nicotine-stimulated release of [3H] norepinephrine from fetal rat locus coeruleus cells in culture","volume":"70","author":"Gallardo","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/depr.3050020202","article-title":"Prefrontal cortex dysfunction in clinical depression","volume":"2","author":"George","year":"1994","journal-title":"Depression"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/JCP.0b013e318172b49e","article-title":"Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study","volume":"28","author":"George","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0306-4530(87)90002-3","article-title":"The stress-induced response of the septo-hippocampal cholinergic system. A vectorial outcome of psychoneuroendocrinological interactions","volume":"12","author":"Gilad","year":"1987","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3565(25)28253-2","article-title":"Uptake and distribution of some quaternary ammonium compounds in the central nervous system of the rat","volume":"167","author":"Gosling","year":"1969","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0095","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2174\/138161206775474486","article-title":"Brain neuronal nicotinic receptors as new targets for drug discovery","volume":"12","author":"Gotti","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0100","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.pbb.2009.09.009","article-title":"Sex differences in tolerance to the locomotor depressant effects of lobeline in periadolescent rats","volume":"94","author":"Harrod","year":"2009","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-3565(24)29365-4","article-title":"Lobeline attenuates d-methamphetamine self-administration in rats","volume":"298","author":"Harrod","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0110","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(72)93021-8","article-title":"A cholinergic\u2013adrenergic hypothesis of mania and depression","volume":"300","author":"Janowsky","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0115","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/ntr\/nts128","article-title":"Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes","volume":"14","author":"Kennett","year":"2012","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0120","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbr.2007.03.022","article-title":"Social defeat, a paradigm of depression in rats that elicits 22-kHz vocalizations, preferentially activates the cholinergic signaling pathway in the periaqueductal gray","volume":"182","author":"Kroes","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0125","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0028-3908(96)00115-3","article-title":"Differential mechanisms involved in the effect of nicotinic agonists DMPP and lobeline to release [3H] 5-HT from rat hippocampal slices","volume":"35","author":"Lendvai","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","article-title":"Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors","volume":"63","author":"Maeng","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0135","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1016\/S0028-3908(00)00140-4","article-title":"Lobeline inhibits nicotine-evoked [3H] dopamine overflow from rat striatal slices and nicotine-evoked 86Rb+ efflux from thalamic synaptosomes","volume":"39","author":"Miller","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0022-3565(24)38847-0","article-title":"Lobeline inhibits the neurochemical and behavioral effects of amphetamine","volume":"296","author":"Miller","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drugalcdep.2007.02.003","article-title":"Lobeline, a potential pharmacotherapy for drug addiction, binds to [mu] opioid receptors and diminishes the effects of opioid receptor agonists","volume":"89","author":"Miller","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0150","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2010.09.004","article-title":"Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis","volume":"31","author":"Mineur","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0155","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.neuropharm.2007.01.006","article-title":"Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL\/6J mice","volume":"52","author":"Mineur","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1124\/jpet.108.149609","article-title":"Cytisine-based nicotinic partial agonists as novel antidepressant compounds","volume":"329","author":"Mineur","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/FBP.0b013e328347546d","article-title":"[alpha] 4 [beta] 2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties","volume":"22","author":"Mineur","year":"2011","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0170","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/(SICI)1098-2396(199708)26:4<392::AID-SYN7>3.0.CO;2-1","article-title":"[125\/123I] IPH: a radioiodinated analog of epibatidine for in vivo studies of nicotinic acetylcholine receptors","volume":"26","author":"Musachio","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0175","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-8993(93)91469-9","article-title":"Presynaptic alterations associated with enhancement of evoked release and synthesis of norepinephrine in hippocampus of chronically cold-stressed rats","volume":"608","author":"Nisenbaum","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0304-3940(93)90289-W","article-title":"The presence of corticotropin-releasing factor-like immunoreactive synaptic vesicles in axon terminals with nicotinic acetylcholine receptor-like immunoreactivity in the median eminence of the rat","volume":"161","author":"Okuda","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0185","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/sj.npp.1300267","article-title":"Altered serotonergic neurotransmission but normal hypothalamic\u2013pituitary\u2013adrenocortical axis activity in mice chronically treated with the corticotropin-releasing hormone receptor type 1 antagonist NBI 30775","volume":"28","author":"Oshima","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0190","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1124\/mol.54.6.1132","article-title":"Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity","volume":"54","author":"Parker","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-010-1932-6","article-title":"Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature","volume":"212","author":"Philip","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0200","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0205","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/neu.10109","article-title":"Desensitization of neuronal nicotinic receptors","volume":"53","author":"Quick","year":"2002","journal-title":"J Neurobiol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00213-006-0568-z","article-title":"The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not \u03b22-or \u03b17-nicotinic acetylcholine receptor subunit knockout mice","volume":"189","author":"Rabenstein","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0215","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0022-3565(25)24494-9","article-title":"Interleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response","volume":"272","author":"Raber","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/157488912800673173","article-title":"Cholinergic receptor system as a target for treating alcohol abuse and dependence","volume":"7","author":"Rahman","year":"2012","journal-title":"Recent Pat CNS Drug Discov"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0225","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2008.10.037","article-title":"The novel nicotinic receptor antagonist N,N\u2032-dodecane-1,12-diyl-bis-3-picolinium dibromide decreases nicotine-induced dopamine metabolism in rat nucleus accumbens","volume":"601","author":"Rahman","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0230","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/0028-3908(90)90022-J","article-title":"Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline","volume":"29","author":"Reavill","year":"1990","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0235","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1472-8206.2003.00160.x","article-title":"Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test","volume":"17","author":"Renard","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0245","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0361-9230(00)00449-4","article-title":"Sexual diergism in rat hypothalamic\u2013pituitary\u2013adrenal axis responses to cholinergic stimulation and antagonism","volume":"54","author":"Rhodes","year":"2001","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0250","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neulet.2011.09.035","article-title":"Neuronal nicotinic receptor antagonist reduces anxiety-like behavior in mice","volume":"504","author":"Roni","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0255","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.pnpbp.2010.11.020","article-title":"Lobeline and cytisine reduce voluntary ethanol drinking behavior in male C57BL\/6J mice","volume":"35","author":"Sajja","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0260","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.pbb.2012.03.017","article-title":"Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL\/6J mice","volume":"102","author":"Sajja","year":"2012","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0265","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000317063","article-title":"Nicotinic ligands modulate ethanol-induced dopamine function in mice","volume":"86","author":"Sajja","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0270","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF02246496","article-title":"Effects of transdermal nicotine on mood and sleep in nonsmoking major depresssed patients","volume":"121","author":"Salin-Pascual","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0275","first-page":"677","article-title":"Nicotine dependence and psychiatric disorders","volume":"55","author":"Salin-Pascual","year":"2003","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0280","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.mp.4001035","article-title":"Nicotinic acetylcholine receptors as targets for antidepressants","volume":"7","author":"Shytle","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0285","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.neuroscience.2006.08.041","article-title":"The involvement of cholinergic and noradrenergic systems in behavioral recovery following oxotremorine treatment to chronically stressed rats","volume":"143","author":"Srikumar","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0290","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0295","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/BF02246215","article-title":"Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats","volume":"117","author":"Stolerman","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0300","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/jpet.300.3.1085","article-title":"Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment","volume":"300","author":"Stout","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s002130050184","article-title":"Nicotinic acetylcholine receptor (nACh-R) agonist-induced changes in brain monoamine turnover in mice","volume":"129","author":"Tani","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.1998.71010258.x","article-title":"Lobeline displaces [3H] dihydrotetrabenazine binding and releases [3H] dopamine from rat striatal synaptic vesicles: comparison with d amphetamine","volume":"71","author":"Teng","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pnpbp.2012.11.011_bb0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s002130050879","article-title":"Antidepressant effects of nicotine in an animal model of depression","volume":"142","author":"Tizabi","year":"1999","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461200293X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858461200293X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T22:42:34Z","timestamp":1745361754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858461200293X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":63,"alternative-id":["S027858461200293X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2012.11.011","relation":{},"ISSN":["0278-5846"],"issn-type":[{"type":"print","value":"0278-5846"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}